Building a Foundation for the Management of Alopecia Areata

Released On
July 31, 2022

Expires On
July 31, 2023

Media Type

Completion Time
30 minutes


Alopecia Areata

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Global Education Group and Excalibur Medical Education.


This activity is supported by an independent educational grant from Pfizer, Inc.

Credit Available

  • Physicians — maximum of 0.50 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of dermatologists. This education may also be of interest to pediatric dermatologists, dermatology advanced practice providers (NPs and PAs), and dermatology nurses as clinicians who are responsible for the primary diagnosis and treatment of patients with AA.

Program Overview

Alopecia areata is an autoimmune disease that targets the hair follicles, typically causing hair loss on the scalp but also on other areas such as the beard and eyebrows. There are many complexities associated with the development and progression of alopecia areata and patients with alopecia may experience periods of hair regrowth and hair loss throughout the course of the disease. This infographic journey provides you with a step-by-step video animation detailing the current understanding of the pathophysiology of alopecia areata as well as an animated video highlighting the burden of the alopecia areata as told through the eyes of the patient.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify the key characteristics that drive the development of alopecia areata, focusing specifically on immunologic pathways that differentiate the condition from other types of hair loss
  • Assess the emotional and psychological burden associated with alopecia areata that may help quickly uncover core quality-of-life issues to be resolved by the patient and healthcare team during routine visits


Amy Fox, MD

Associate Professor
Department of Dermatology
University of North Carolina School of Medicine
Chapel Hill, NC

Brittany Craiglow, MD

Adjunct Assistant Professor
Department of Dermatology
Yale University School of Medicine
New Haven, CT

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Excalibur Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term Offering
This activity was released on July 31, 2022 and is valid for one year. Requests for credit must be made no later than July 31, 2023.

Disclosures of Conflicts of Interest

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Brittany Craiglow
  • Consulting Fee (e.g. advisory board): Eli Lilly, Regeneron, Sanofi-Genzyme, Pfizer
  • Honoraria: Eli Lilly, Regeneron, Sanofi-Genzyme, Pfizer
Amy Fox
  • Stock Shareholder: CVS Health, Doximity, GoodRX, 3M

The planners and managers have the following relevant financial relationships with ineligible companies:

Lindsay Borvansky, has nothing to disclose.
Andrea Funk, has nothing to disclose.
Liddy Knight, has nothing to disclose.
Ashley Cann, has nothing to disclose.
Scott Kober, has nothing to disclose.
Audrie Tornow, has nothing to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

Certificates are available for download at the completion of the activity.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Excalibur Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or